16 http://www.ukbonn.de ORG-0001 Universitätsklinikum Bonn AöR Venusberg-Campus 1 Bonn 53127 DEA22 DEU DE 811 917 555 GB4-Abteilung Einkauf +49 228 287-14798 einkauf@ukbonn.de ORG-0002 Vergabekammer Rheinland bei der Bezirksregierung Köln, Spruchkörper Köln Köln 50606 DEA23 DEU 05315-03002-81 +49 2211473116 VKRheinland@bezreg-koeln.nrw.de 2.3 eforms-de-2.1 eforms-sdk-1.13 bda8c7e2-8c36-488a-bab5-63b0ab45ed0d 82d291a6-fcaa-4160-a796-fa13f323dd2f 2026-03-31+02:00 11:38:12+02:00 01 2026-03-31+02:00 32014L0024 cn-standard DEU anst-oer-land health ORG-0001 false false no-eu-funds false vgv DEU SomeTenderDocID1 non-restricted-document nati-ground crime-org terr-offence finan-laund fraud corruption human-traffic tax-pay socsec-pay envir-law socsec-law labour-law insolvency liq-admin susp-act bankr-nat prof-misconduct distorsion partic-confl prep-confl sanction misrepresent epo-notice ORG-0001 Competition Act (Gesetz gegen Wettbewerbsbeschränkungen - GWB), Section 160: (1) The public procurement tribunal shall initiate review proceedings only upon application. (2) Every undertaking that has an interest in the public contract or the concession and claims that its rights under Section 97(6) have been violated by non-compliance with the provisions governing the awarding of public contracts has the right to file an application. In doing so, the undertaking must show that it has been or risks being harmed by the alleged violation of public procurement provisions. (3) The application is inadmissible if 1. the applicant became aware of the claimed violation of public procurement provisions before filing the application for review, but did not complain to the contracting authority within a time limit of 10 calendar days; the expiry of the time limit under Section 134(2) remains unaffected, 2. violations of public procurement provisions which become apparent from the tender notice are not notified to the contracting authority by the end of the time limit for the application or the submission of a tender specified in the notice, 3. violations of public procurement provisions which only become apparent from the procurement documents are not notified to the contracting authority by the end of the time limit for the application or the submission of a tender specified in the notice, 4. more than 15 calendar days have expired since receipt of notification from the contracting entity that it is unwilling to redress the objection. Sentence 1 shall not apply to an application under Section 135(1) no 2 to have the contract declared ineffective. Section 134(1) sentence 2 shall remain unaffected. ORG-0002 DEU ENG open https://www.evergabe.nrw.de/VMPSatellite/notice/CXPNY5YDVU9 true Mittelverfall zum Ende Februar 2026 false 2026-08 Toxicology and Safety Pharmacology Studies The procurement, published by means of the contract notice in the relevant world-wide publications, concerns the conduct of a toxicology and safety pharmacology studies, GLP in vitro and in vivo study for an anti-parasitic drug of DNDi. services #Bekanntmachungs-ID: CXPNY5YDVU9# 73000000 73000000 73000000 anyw LOT-0001 slc-suit-reg-prof By certificate: Proof of registration in a public register (e.g. commercial or trade central register; not older than three months) or comparable. slc-stand-other By certificate: Proof of an existing business/professional liability insurance policy. slc-abil-facil-res By certificate: Proof of AAALAC accreditation slc-abil-facil-res By written statement: Proof of ethical clearance to work with canines. slc-abil-facil-res By written statement: Demonstration of knowledge of conducting Dirofilaria immitis in vivo efficacy studies, e.g. publication history, list of references or equivalent. false false not-allowed no-eu-funds allowed false DEU SomeTenderDocID1 non-restricted-document https://www.evergabe.nrw.de/VMPSatellite/notice/CXPNY5YDVU9/documents false late-some Procurement Ordinance (Vergabeverordnung - VgV), section 56: (2) The contracting entity may, in compliance with the principles of transparency and equal treatment, ask the candidate or tenderer to complete, send on or correct any incomplete, missing or incorrect business-related documents, particularly selfdeclarations, statements, certificates or other means of proof, or to complete or send on any incomplete or missing documents related to the performance. The contracting entity is entitled to state in the contract notice or procurement documents that it will not follow up with requests for documents. (3) Follow-up requests for performance-related documents concerning the economic evaluation of the tenders using the award criteria are excluded. This shall not apply to pricing, provided only non-essential individual entries are involved, the individual prices of which do not change the overall price or adversely affect the evaluation sequence and the competition. (4) Following the contracting entity"s request, the documents shall be submitted by the candidate or tenderer within a reasonable time limit to be set by the contracting entity according to a calendar date. none epo-notice no not-allowed required performance Specifications of the required services are set out in the document "B01 Service Specifications". The services shall be governed by the enclosed Master Contract Services Agreement (document B02). false ORG-0001 https://www.evergabe.nrw.de/VMPSatellite/notice/CXPNY5YDVU9 ORG-0001 2 Competition Act (Gesetz gegen Wettbewerbsbeschränkungen - GWB), Section 160: (1) The public procurement tribunal shall initiate review proceedings only upon application. (2) Every undertaking that has an interest in the public contract or the concession and claims that its rights under Section 97(6) have been violated by non-compliance with the provisions governing the awarding of public contracts has the right to file an application. In doing so, the undertaking must show that it has been or risks being harmed by the alleged violation of public procurement provisions. (3) The application is inadmissible if 1. the applicant became aware of the claimed violation of public procurement provisions before filing the application for review, but did not complain to the contracting authority within a time limit of 10 calendar days; the expiry of the time limit under Section 134(2) remains unaffected, 2. violations of public procurement provisions which become apparent from the tender notice are not notified to the contracting authority by the end of the time limit for the application or the submission of a tender specified in the notice, 3. violations of public procurement provisions which only become apparent from the procurement documents are not notified to the contracting authority by the end of the time limit for the application or the submission of a tender specified in the notice, 4. more than 15 calendar days have expired since receipt of notification from the contracting entity that it is unwilling to redress the objection. Sentence 1 shall not apply to an application under Section 135(1) no 2 to have the contract declared ineffective. Section 134(1) sentence 2 shall remain unaffected. ORG-0002 DEU ENG true false false required true https://www.evergabe.nrw.de/VMPSatellite/notice/CXPNY5YDVU9 2026-04-30+02:00 23:59:00+02:00 2026-04-22+02:00 23:59:59+02:00 2026-05-04+02:00 08:00:00+02:00 false none none 2026-08 Toxicology and Safety Pharmacology Studies The University Hospital Bonn aims to progress the investigational compound E4095372 for treatment of helminth infections in humans. For this, the University Hospital Bonn is looking for a contract research organization (CRO) to conduct GLP safety and toxicology studies in rats. The maximum treatment time will be 28 days. The entire process will be awarded to the CRO as a single-phase contract. A Master Service Agreement (MSA) or framework agreement is preferred to facilitate the commission of the required work packages in form of Statements of Work (SoWs). There will be a commercial agreement and an additional quality assurance agreement. services false inn-pur The procurement, published by means of the contract notice in the relevant world-wide publications, concerns the conduct of a toxicology and safety pharmacology studies, GLP in vitro and in vivo study for an anti-parasitic drug of DNDi. rd-act 73000000 73000000 73000000 anyw UNKNOWN